Back to search
FDAFDA · Food and drugs·Recall number D-0706-2017

Alprazolam Extended-release Tablets, USP, 1 mg, 60-count bottle, Rx Only, Manufactured and Distributed by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5022-91

Published May 31, 2017 · Recall initiated: June 22, 2016

Summary

FDA records drug Class II recall D-0706-2017, published May 31, 2017 and initiated June 22, 2016. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 24,176 bottles (1,450,560 tablets); Lot: Code: 0378-5022-91 Lot: 3065878; Exp. 04/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Nationwide
Lot
Code: 0378-5022-91 Lot: 3065878; Exp. 04/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Alprazolam Extended-release Tablets, USP, 1 mg, 60-count bottle, Rx Only, Manufactured and Distributed by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5022-91 recalled?

Yes. FDA published recall D-0706-2017 on May 31, 2017. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail